LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219 | -17.0% | 3,658 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $264 | -99.9% | 3,658 | +15.8% | 0.00% | -50.0% |
| Q2 2022 | $282,000 | -20.6% | 3,158 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $355,000 | -27.3% | 3,158 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $488,000 | +37.1% | 3,158 | +23.5% | 0.00% | 0.0% |
| Q3 2021 | $356,000 | +6.0% | 2,558 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $336,000 | -6.4% | 2,558 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $359,000 | -6.5% | 2,358 | -38.9% | 0.00% | 0.0% |
| Q4 2020 | $384,000 | +4.3% | 3,858 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $368,000 | -57.4% | 3,858 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $864,000 | – | 7,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |